查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576950

眼科用雷射的全球市场:洞察，竞争情形，市场预测:2030年

Ophthalmic Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球眼科雷射市场规模达12.5亿美元。预计到 2030 年，该市场将达到 17.8 亿美元，2024 年至 2030 年的预测期间复合年增长率为 6.11%。青光眼、糖尿病视网膜病变、老年黄斑部病变（AMD）和白内障等眼科疾病盛行率的上升是眼科雷射市场的关键推动因素。此外，由于微创手术具有更快的恢復时间、降低併发症风险和减轻疼痛等优点，患者和医疗保健提供者都强烈偏好微创手术。此外，2024年至2030年，主要市场参与者将继续投资研发以推出创新的眼科雷射、增加伙伴关係和协作以及产品的发布和批准。 。

根据世界卫生组织 (WHO) (2023) 提供的最新数据和统计数据，全球至少有 22 亿人出现近距离视力或远视力丧失。其中，约有 10 亿人仍未解决。在这群人中，远视力障碍和失明的主要原因是白内障（影响9,400 万人）、屈光不正（影响8,840 万人）和老年黄斑部病变（影响800 万人）（影响770 万人） 。老花眼是近距离视力障碍的主要原因，影响 8.26 亿人。

因此，随着糖尿病视网膜病变、青光眼和老年黄斑部病变等疾病发生率的增加，对有效、微创治疗的需求不断增长。眼科雷射提供精确且有针对性的治疗，可以比传统方法更有效地治疗这些疾病。例如，雷射治疗糖尿病视网膜病变和视网膜静脉阻塞可以防止视力丧失并改善预后。飞秒雷射和 YAG 雷射等创新雷射技术的进步扩大了可治疗疾病的范围并提高了治疗效果。

此外，全球范围内不断增加的产品开发活动进一步推动了整个眼科雷射市场的发展。例如，2024 年 1 月，领先的雷射医疗设备供应商 IRIDEX Corporation 在美国宣布推出采用 IRIDEX 532 和 IRIDEX 577 雷射器的下一代平台。这些先进的雷射专为治疗视网膜疾病和青光眼而设计，并提供多种治疗模式，包括连续波和 Iridex 专有的微脉衝技术。该平台还拥有直觉的触控萤幕介面，提供对各种临床控制和设置的访问，提高了易用性和治疗准确性。

因此，上述因素可能会在预测期内推动眼科雷射市场的发展。

然而，使用眼科雷射设备后发生感染的风险以及对产品审批的严格监管担忧可能会阻碍眼科雷射的未来市场。

本报告提供全球眼科用雷射市场相关调查，提供市场概要，以及各产品类型，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 眼科用雷射市场报告的简介

第2章 眼科用雷射市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 眼科用雷射市场主要原因分析

  • 眼科用雷射的市场促进因素
  • 眼科用雷射的市场阻碍因素与课题
  • 眼科用雷射的市场机会

第6章 眼科用雷射市场上波特的五力分析

第7章 眼科用雷射市场评估

  • 各产品类型
  • 各用途
  • 各终端用户
  • 各地区

第8章 眼科用雷射市场企业与产品的简介

  • Alcon Inc.
  • IRIDEX Corporation
  • Alna-Medicalsystem AG & Co. KG
  • BAUSCH + LOMB INCORPORATED
  • Lumenis Be Ltd.
  • Abbott
  • NIDEK CO., LTD.
  • MERIDIAN AG
  • Johnson & Johnson Vision
  • LIGHTMED
  • ZEISS
  • Navilas Academy
  • Aeon Meditec
  • Quantel Medical
  • Lumibird Medical
  • Ziemer Ophthalmic Systems AG
  • Novartis AG
  • Lumenis
  • Canon Medical Systems
  • Optovue

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0510

Ophthalmic Lasers Market by Product Type (Argon Blue-Green Laser, ND: Yag Laser, Femtosecond Lasers, Krypton Red Laser, and Others), Application (Glaucoma, Diabetic Retinopathy, Cataracts, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the surge in the prevalence of ophthalmic diseases such as glaucoma, diabetic retinopathy, and others, growing preference for minimally invasive procedures, and increase in product launches and approvals by key market players across the globe.

The global ophthalmic laser devices market was valued at USD 1.25 billion in 2023, growing at a CAGR of 6.11% during the forecast period from 2024 to 2030, to reach USD 1.78 billion by 2030. The rising prevalence of ophthalmic diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and cataracts are the major drivers for the ophthalmic lasers market. Additionally, a strong preference among patients and healthcare providers for minimally invasive procedures due to their benefits, including shorter recovery times, reduced risk of complications, and less pain. Furthermore, key market players continuously investing in research and development to introduce innovative ophthalmic lasers, increased partnerships and collaborations, product launches and approvals are some of the key factors boosting the market for ophthalmic lasers, during the forecast period from 2024 to 2030.

Ophthalmic Lasers Market Dynamics:

According to the recent data and stats provided by the World Health Organization (2023), globally, at least 2.2 billion people experienced near or distance vision impairment. Of these, approximately 1 billion cases remained unaddressed. Among this group, the leading causes of distance vision impairment or blindness included cataracts, affecting 94 million people; refractive errors, impacting 88.4 million; age-related macular degeneration, which affected 8 million; glaucoma, with 7.7 million cases; and diabetic retinopathy, affected 3.9 million. Presbyopia was the primary condition causing near vision impairment, affecting 826 million people.

Thus, as the incidence of conditions like diabetic retinopathy, glaucoma, and age-related macular degeneration rises, there is a growing demand for effective, minimally invasive treatments. Ophthalmic lasers offer precise, targeted therapies that can manage these disorders more efficiently than traditional methods. For instance, laser treatments for diabetic retinopathy and retinal vein occlusions can prevent vision loss and improve outcomes. The advancement of laser technology, with innovations such as femtosecond and YAG lasers, expanded the range of treatable conditions and enhanced procedural efficacy, driving further adoption in clinical settings and hence driving the market growth of ophthalmic laser across the globe.

Additionally, the increase in product development activities across the globe is further boosting the overall market of ophthalmic lasers. For instance, in January 2024, IRIDEX Corporation, a leading provider of laser-based medical equipment, unveiled its next-generation platform featuring the IRIDEX 532 and IRIDEX 577 lasers in the United States. These advanced lasers were designed for the treatment of retinal diseases and glaucoma, offering a range of treatment modes, including continuous-wave and IRIDEX's exclusive MicroPulse technology. The platform also boasts an intuitive touchscreen interface that provided the access to various clinical control features and settings, enhancing ease of use and precision in treatment.

Thus, the factors mentioned above are likely to boost the market of ophthalmic lasers during the forecasted period.

However, the risk of developing infection after the use of an ophthalmic laser device and stringent regulatory concerns for product approval may hinder the future market of ophthalmic lasers.

Ophthalmic Lasers Market Segment Analysis:

Ophthalmic Lasers Market by Product Type (Argon Blue-Green Laser, ND: Yag Laser, Femtosecond Lasers, Krypton Red Laser, and Others), Application (Glaucoma, Diabetic Retinopathy, Cataracts, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the ophthalmic lasers market, femtosecond lasers is projected to hold a considerable market share in 2023. Femtosecond lasers can significantly boost the ophthalmic laser market through their advanced capabilities and the benefits they offer over traditional methods. These lasers operate at incredibly short pulse durations-femtoseconds (one quadrillionth of a second)-allowing for precise and controlled tissue disruption with minimal thermal damage. This precision are particularly advantageous in delicate eye surgeries, such as cataract surgery, where femtosecond lasers are used to perform tasks like corneal incision, lens fragmentation, and capsulotomy with high accuracy. By enhancing surgical outcomes and reducing complications, femtosecond lasers contribute to better patient experiences and quicker recoveries, which in turn increases their adoption among both surgeons and patients. The technology also allows for customized treatments, as surgeons can tailor the laser's parameters to each patient's specific anatomy and condition, further improving efficacy and safety. As a result, femtosecond lasers drive market growth by expanding the range of treatable conditions, enhancing procedural success rates, and encouraging investment in advanced ophthalmic technologies. This growth is further supported by ongoing advancements in laser technology and increasing patient demand for minimally invasive, precise, and effective treatment options.

Additionally, the increasing product approval across the globe are further propelling the market of the segment. For instance, In April 2023, Johnson & Johnson Vision, a global leader in eye health and part of Johnson & Johnson MedTech received U.S Food and Drug Administration FDA 510(k) approval on their ELITA Femtosecond Laser.

Therefore, owing to the above-mentioned factors, the femtosecond lasers category is expected to generate considerable revenue thereby pushing the overall growth of the global ophthalmic lasers market during the forecast period.

North America is expected to dominate the overall Ophthalmic Lasers market:

Among all the regions, North America is expected to hold the largest share in the global ophthalmic lasers market in 2023. The ophthalmic lasers market in North America is witnessing growth due to several factors like rising incidence of eye disorders like diabetic retinopathy and glaucoma across the region. Additionally, the market is benefited from the presence of prominent industry players and ongoing product development initiatives, including new launches and regulatory approvals. These factors collectively contribute to the expansion of the ophthalmic lasers market in North America, catering to the increasing demand for advanced treatments and technologies in eye care.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2023), in 2021 it was estimated that in the United States, around 9.6 million people with diabetes, or 2.6%, have diabetic retinopathy (DR), and 1.84 million, or 5.1% of those with diabetes, had vision-threatening diabetic retinopathy (VTDR). Among people over the age of 40 years with diabetes, approximately 1 in 4 had diabetic retinopathy. The prevalence of DR is highest (28.4%) in the 65-79 age group and lowest (13.0%) in those under 25. Overall, there were 8.94 million cases of diabetic retinopathy and 1.71 million cases of vision-threatening diabetic retinopathy among people aged 40 and above. Thus, the increasing prevalence of diabetic retinopathy (DR) in North America, is driving demand for ophthalmic lasers.

Furthermore, recent merger, acquisitions, and approvals among key market players in the region further propels the market across the region. For example, in September 2023, MERIDIAN AG got the approval from the U.S. Food and Drug Administration (FDA) for their innovative Merilas product family which was developed by MERIDIAN AG for the treatment of retinal disorder and glaucoma. Therefore, increasing product approvals, and launches of the product along with the presence of key players, among others is expected to boost the growth of the ophthalmic lasers market in the North American region during the forecast period from 2024 to 2030.

Ophthalmic Lasers Market Key Players:

Some of the key market players operating in the ophthalmic lasers market include Alcon Inc., IRIDEX Corporation, Alna-Medicalsystem AG & Co. KG, BAUSCH + LOMB INCORPORATED, Lumenis Be Ltd., Abbott, NIDEK CO., LTD, MERIDIAN AG, Johnson & Johnson Vision, LIGHTMED, ZEISS, Navilas Academy, Aeon Meditec, Quantel Medical, Lumibird Medical, Ziemer Ophthalmic Systems AG, Novartis, Lumenis, Canon Medical Systems, Optovue, and others.

Recent Developmental Activities in the Ophthalmic Lasers Market:

  • In January 2024, MERIDIAN AG received the U.S. Food and Drug Administration (FDA) approval for their MR Q series, this product provided a high-quality and inventive healthcare solution that required the needs of patients and physicians around the world.
  • In March 2021, IRIDEX Corporation, announced a collaboration with Topcon Corporation a Japanese manufacturer and distributor of the eye care business to expand their market of ophthalmic lasers in Asia-Pacific.

Key Takeaways From the Ophthalmic Lasers Market Report Study:

  • Market size analysis for current ophthalmic lasers size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the ophthalmic lasers market.
  • Various opportunities available for the other competitors in the ophthalmic lasers market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current ophthalmic lasers market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for ophthalmic lasers market growth in the coming future?

Target Audience who can be Benefited From This Ophthalmic Lasers Market Report Study:

  • Ophthalmic lasers product providers
  • Research organizations and consulting companies
  • Ophthalmic lasers -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in ophthalmic lasers
  • Various end-users who want to know more about the ophthalmic lasers market and the latest technological developments in the ophthalmic lasers market.

Frequently Asked Questions for the Ophthalmic Lasers Market:

1. What are ophthalmic lasers?

  • An ophthalmic laser is a medical device used in eye care to perform precise and controlled procedures on the eye. It utilizes focused light beams to treat various eye conditions, including cataracts, glaucoma, and retinal disorders, by either cutting, reshaping, or stimulating tissues with minimal invasiveness.

2. What is the market for ophthalmic lasers?

  • The global ophthalmic laser devices market was valued at USD 1.25 billion in 2023, growing at a CAGR of 6.11% during the forecast period from 2024 to 2030, to reach USD 1.78 billion by 2030.

3. What are the drivers for the ophthalmic lasers market?

  • The rising prevalence of ophthalmic diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and cataracts is a major driver of the ophthalmic laser market. Additionally, a strong preference among patients and healthcare providers for minimally invasive procedures due to their benefits, including shorter recovery times, reduced risk of complications, and less pain. Further, key market players continuously investing in research and development to introduce innovative ophthalmic lasers, increased partnerships and collaborations, product launches and approvals ensures that market remains dynamic and innovative, during the forecast period from 2024 to 2030.

4. Who are the key players operating in the ophthalmic lasers market?

  • Some of the key market players operating in the ophthalmic lasers market include Alcon Inc., IRIDEX Corporation, Alna-Medicalsystem AG & Co. KG, BAUSCH + LOMB INCORPORATED, Lumenis Be Ltd., Abbott, NIDEK CO., LTD, MERIDIAN AG, Johnson & Johnson Vision, LIGHTMED, ZEISS, Navilas Academy, Aeon Meditec, Quantel Medical, Lumibird Medical, Ziemer Ophthalmic Systems AG, Novartis, Lumenis, Canon Medical Systems, Optovue, and others.

5. Which region has the highest share in the ophthalmic lasers market?

  • North America is expected to hold the largest share in the global ophthalmic lasers market in 2023. This can be attributed to the rising incidence of eye disorders such as diabetic retinopathy and glaucoma across the region. Additionally, the market is benefited from the presence of prominent industry players and ongoing product development initiatives, including new launches and regulatory approvals. These factors collectively contribute to the expansion of the ophthalmic lasers market in North America, catering to the increasing demand for advanced treatments and technologies in eye care.

Table of Contents

1. Ophthalmic Lasers Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Ophthalmic Lasers Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Ophthalmic Lasers Market Key Factors Analysis

  • 5.1. Ophthalmic Lasers Market Drivers
    • 5.1.1. Growing prevalence of ophthalmic diseases such as glaucoma, diabetic retinopathy, and others
    • 5.1.2. Growing preference for minimally invasive procedures
    • 5.1.3. Increase in product launches and approvals by key market players across the globe.
  • 5.2. Ophthalmic Lasers Market Restraints and Challenges
    • 5.2.1. Risk of developing infection after the use of ophthalmic lasers
    • 5.2.2. Stringent regulatory concerns for product approval
  • 5.3. Ophthalmic Lasers Market Opportunities
    • 5.3.1. Integration of artificial intelligence in the field of ophthalmology lasers

6. Ophthalmic Lasers Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Ophthalmic Lasers Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Argon blue-green laser
    • 7.1.2. ND: YAG Laser
    • 7.1.3. Femtosecond Lasers
    • 7.1.4. Krypton Red lasers
    • 7.1.5. Others
  • 7.2. By Application
    • 7.2.1. Glaucoma
    • 7.2.2. Diabetic Retinopathy
    • 7.2.3. Cataracts
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmic Clinics
    • 7.3.3. Ambulatory Surgical Centers
    • 7.3.4. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Ophthalmic Lasers Market Size in USD Million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.2.6. Rest of Europe Ophthalmic Lasers Market Size in USD Million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.3.3. India Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Ophthalmic Lasers Market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Ophthalmic Lasers Market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Ophthalmic Lasers Market Size in USD Million (2021-2030)

8. Ophthalmic Lasers Market Company and Product Profiles

  • 8.1. Alcon Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. IRIDEX Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Alna-Medicalsystem AG & Co. KG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. BAUSCH + LOMB INCORPORATED
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Lumenis Be Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Abbott
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. NIDEK CO., LTD.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. MERIDIAN AG
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Johnson & Johnson Vision
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. LIGHTMED
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. ZEISS
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Navilas Academy
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Aeon Meditec
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Quantel Medical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Lumibird Medical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Ziemer Ophthalmic Systems AG
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Novartis AG
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Lumenis
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Canon Medical Systems
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Optovue
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Ophthalmic Lasers Market in Global (2021-2030)
  • Table 3: Ophthalmic Lasers Market in Global by Product Type (2021-2030)
  • Table 4: Ophthalmic Lasers Market in Global by Application (2021-2030)
  • Table 5: Ophthalmic Lasers Market in Global by End-User (2021-2030)
  • Table 6: Ophthalmic Lasers Market in Global by Geography (2021-2030)
  • Table 7: Ophthalmic Lasers Market in North America (2021-2030)
  • Table 8: Ophthalmic Lasers Market in the United States (2021-2030)
  • Table 9: Ophthalmic Lasers Market in Canada (2021-2030)
  • Table 10: Ophthalmic Lasers Market in Mexico (2021-2030)
  • Table 11: Ophthalmic Lasers Market in Europe (2021-2030)
  • Table 12: Ophthalmic Lasers Market in France (2021-2030)
  • Table 13: Ophthalmic Lasers Market in Germany (2021-2030)
  • Table 14: Ophthalmic Lasers Market in United Kingdom (2021-2030)
  • Table 15: Ophthalmic Lasers Market in Italy (2021-2030)
  • Table 16: Ophthalmic Lasers Market in Spain (2021-2030)
  • Table 17: Ophthalmic Lasers Market in the Rest of Europe (2021-2030)
  • Table 18: Ophthalmic Lasers Market in Asia-Pacific (2021-2030)
  • Table 19: Ophthalmic Lasers Market in China (2021-2030)
  • Table 20: Ophthalmic Lasers Market in Japan (2021-2030)
  • Table 21: Ophthalmic Lasers Market in India (2021-2030)
  • Table 22: Ophthalmic Lasers Market in Australia (2021-2030)
  • Table 23: Ophthalmic Lasers Market in South Korea (2021-2030)
  • Table 24: Ophthalmic Lasers Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Ophthalmic Lasers Market in the Rest of the World (2021-2030)
  • Table 26: Ophthalmic Lasers Market in the Middle East (2021-2030)
  • Table 27: Ophthalmic Lasers Market in Africa (2021-2030)
  • Table 28: Ophthalmic Lasers Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Ophthalmic Lasers Market in Global (2021-2030)
  • Figure 3: Ophthalmic Lasers Market in Global by Product Type (2021-2030)
  • Figure 4: Ophthalmic Lasers Market in Global by Application (2021-2030)
  • Figure 5: Ophthalmic Lasers Market in Global by End-User (2021-2030)
  • Figure 6: Ophthalmic Lasers Market in Global by Geography (2021-2030)
  • Figure 7: Ophthalmic Lasers Market in North America (2021-2030)
  • Figure 8: Ophthalmic Lasers Market in the United States (2021-2030)
  • Figure 9: Ophthalmic Lasers Market in Canada (2021-2030)
  • Figure 10: Ophthalmic Lasers Market in Mexico (2021-2030)
  • Figure 11: Ophthalmic Lasers Market in Europe (2021-2030)
  • Figure 12: Ophthalmic Lasers Market in France (2021-2030)
  • Figure 13: Ophthalmic Lasers Market in Germany (2021-2030)
  • Figure 14: Ophthalmic Lasers Market in United Kingdom (2021-2030)
  • Figure 15: Ophthalmic Lasers Market in Italy (2021-2030)
  • Figure 16: Ophthalmic Lasers Market in Spain (2021-2030)
  • Figure 17: Ophthalmic Lasers Market in the Rest of Europe (2021-2030)
  • Figure 18: Ophthalmic Lasers Market in Asia-Pacific (2021-2030)
  • Figure 19: Ophthalmic Lasers Market in China (2021-2030)
  • Figure 20: Ophthalmic Lasers Market in Japan (2021-2030)
  • Figure 21: Ophthalmic Lasers Market in India (2021-2030)
  • Figure 22: Ophthalmic Lasers Market in Australia (2021-2030)
  • Figure 23: Ophthalmic Lasers Market in South Korea (2021-2030)
  • Figure 24: Ophthalmic Lasers Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Ophthalmic Lasers Market in the Rest of the World (2021-2030)
  • Figure 26: Ophthalmic Lasers Market in the Middle East (2021-2030)
  • Figure 27: Ophthalmic Lasers Market in Africa (2021-2030)
  • Figure 28: Ophthalmic Lasers Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 31: PORTER'S Five Force Analysis